M&A, Due Diligence
Mergers and acquisitions (M&A) refer to the consolidation of companies or their major assets through financial transactions. Although mergers and acquisitions are used interchangeably, they come with different legal meanings. Due diligence is a key part of the M&A process.
The main reasons for M&A activity include synergy, growth, market power, the acquisition of unique capabilities, assets and resources, diversification, increased earnings, management's personal incentives, tax considerations, and the possibilities of uncovering hidden value.
Epstein (2005) proposed six determinants of merger success: due diligence, strategic vision and fit, deal structure, pre-merger planning, external factors, and post-merger integration.
Due diligence is usually the most time-consuming and critical part of any M&A transaction. M&A due diligence requires a detailed examination and analysis of the target company from both internal and external sources. This helps verify the target's value and identifies risks and liabilities. Key steps include:
Assessment and preliminary review
Negotiation and letter of intent
Due diligence
Negotiations and closing
Post-closure integration/implementation
Manage collaboration effectively
Create more value together
Best Practices
Leverage our deep knowledge and tested strategies.
M&A has a high failure and value-destruction rate, in order to succeed it is very important to not only focus on the product and market fit, but also the people and culture fit. Synergies and growth potential are often overestimated. Being realistic, getting the right advice and conducting thorough due diligence is critical.
Successful acquirers consider several factors to determine the priority for possible targets to consider:
Steady growth rate
Product portfolio diversification
Profitability
History of innovation
Market leadership or niche speciality
Management team
Special legal, regulatory or environmental issues
Case Study
How Hardian solves the problem.
The digital health sector is one of the most promising and exciting investment opportunities coming out of the current trend in machine learning and technological advancement. But, deep experience and knowledge are required to navigate the health tech sector, particularly in cutting-edge fields of AI and software-driven tools. Hardian has partnered with multiple prominent venture capitalists and private equity firms such as Bowmark Capital, to advise capital allocators through the common pitfalls within health tech. Our vast network and tiered Due Diligence processes are tailored to complement your financial analysis to inform investment decisions with specialist knowledge.
Get in touch
Get in touch to discuss how Hardian Health can help you with M&A strategy and Due Diligence.